Eli Lilly
LLY
$425.79
Share price
-0.36%
Change (1 day)
35.84%
Change (1 year)
Categories
With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
Eli Lilly (LLY) - Total assets
Total assets on the balance sheet as of March 2023 : $53.16 B
According to Eli Lilly's latest financial reports the company's total assets are $53.16 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Eli Lilly - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $49.48 B | 1.4% |
| 2021-12-31 | $48.80 B | 4.66% |
| 2020-12-31 | $46.63 B | 18.7% |
| 2019-12-31 | $39.28 B | -10.53% |
| 2018-12-31 | $43.90 B | -2.38% |
| 2017-12-31 | $44.98 B | 15.91% |
| 2016-12-31 | $38.80 B | 9.1% |
| 2015-12-31 | $35.56 B | -4.33% |
| 2014-12-31 | $37.17 B | 5.47% |
| 2013-12-31 | $35.24 B | 2.47% |
| 2012-12-31 | $34.39 B | 2.2% |
| 2011-12-31 | $33.65 B | 8.58% |
| 2010-12-31 | $31.00 B | 12.89% |
| 2009-12-31 | $27.46 B | -6% |
| 2008-12-31 | $29.21 B | 9.05% |
| 2007-12-31 | $26.78 B | 22.01% |
| 2006-12-31 | $21.95 B | -10.68% |
| 2005-12-31 | $24.58 B | -1.15% |
| 2004-12-31 | $24.86 B | 14.71% |
| 2003-12-31 | $21.67 B | 13.84% |
| 2002-12-31 | $19.04 B | 15.87% |
| 2001-12-31 | $16.43 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $187.37 B | 252.46% | 🇺🇸 USA |
 Novartis NVS | $112.24 B | 111.13% | 🇨🇭 Switzerland |
 Pfizer PFE | $197.20 B | 270.94% | 🇺🇸 USA |
 AbbVie ABBV | $138.80 B | 161.09% | 🇺🇸 USA |
 Amgen AMGN | $88.72 B | 66.88% | 🇺🇸 USA |
 Sanofi SNY | $135.71 B | 155.28% | 🇫🇷 France |
 Merck MRK | $109.16 B | 105.33% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $94.28 B | 77.34% | 🇺🇸 USA |
 AstraZeneca AZN | $96.68 B | 81.87% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $72.58 B | 36.53% | 🇬🇧 UK |